Fagron NV
OTC:ARSUF

Watchlist Manager
Fagron NV Logo
Fagron NV
OTC:ARSUF
Watchlist
Price: 26.807 USD 14.07% Market Closed
Market Cap: 2B USD

Operating Margin

15.3%
Current
Improving
by 0.5%
vs 3-y average of 14.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.3%
=
Operating Income
€140.2m
/
Revenue
€918.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
15.3%
=
Operating Income
$140.2m
/
Revenue
€918.8m

Peer Comparison

Country Company Market Cap Operating
Margin
BE
Fagron NV
XBRU:FAGR
1.7B EUR
Loading...
US
Mckesson Corp
NYSE:MCK
104.2B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
68.9B USD
Loading...
US
Cencora Inc
NYSE:COR
68.8B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.6B USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
33.9B AUD
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
67.5B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.2B CNY
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
63.6B HKD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Belgium
Percentile
58th
Based on 476 companies
58th percentile
15.3%
Low
-11 800% — 4.9%
Typical Range
4.9% — 26.6%
High
26.6% — 45 050%
Distribution Statistics
Belgium
Min -11 800%
30th Percentile 4.9%
Median 11%
70th Percentile 26.6%
Max 45 050%

Fagron NV
Glance View

Fagron NV is a Belgian multinational company that has woven specialized pharmaceutical compounding into the fabric of modern healthcare. Founded in 1990, the company's mission has always been to advance personalized medicine by focusing on the compounding sector, which involves tailoring and mixing pharmaceutical ingredients to produce unique medications tailored to the specific needs of patients. By transforming individual healthcare demands into bespoke pharmaceutical solutions, Fagron serves the global medical community by manufacturing and distributing both active and inactive pharmaceutical ingredients, as well as offering various base products. This strategic positioning not only supports healthcare professionals and pharmacies in delivering specialized patient care but also fortifies the company's commitment to improving global health outcomes. The key to Fagron's business model lies in its adept integration of innovation alongside therapeutic and technological solutions, ensuring they maintain a strong presence within the compounding market. The company particularly thrives on its ability to address niches in the pharmaceutical industry, ones often overlooked by large pharma entities due to scale inefficiencies. Through its three principal segments—Pharmaceutical Compounding, Raw Materials, and Innovative Concepts—Fagron generates revenue by supplying pharmacies and medical institutions worldwide, from small community pharmacies to large hospital networks. Its broad portfolio of over 30,000 products caters to a spectrum of needs, fostering both patient-specific and bulk pharmaceutical solutions. By combining quality, safety, and regulatory compliance with a keen market understanding, Fagron NV continues to sustain its role as a crucial player in the personalized medicine arena.

ARSUF Intrinsic Value
32.578 USD
Undervaluation 18%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
15.3%
=
Operating Income
€140.2m
/
Revenue
€918.8m
What is Fagron NV's current Operating Margin?

The current Operating Margin for Fagron NV is 15.3%, which is above its 3-year median of 14.8%.

How has Operating Margin changed over time?

Over the last 3 years, Fagron NV’s Operating Margin has increased from 14.9% to 15.3%. During this period, it reached a low of 14.3% on Jun 30, 2023 and a high of 15.3% on Dec 31, 2024.

Back to Top